Other Appointments/Positions

Co-Director Core Laboratory, Emory Crawford Long Hospital

Director of Point of Care, Emory Medical Laboratories

Pathology Division(s):
Clinical Pathology

Email Address:
cfantz@emory.edu

Education:

PhD   Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina., 1998 -

BA   Biology and Chemistry, Columbia College, Columbia, South Carolina, Majors: Biology and Chemistry, Minor: Mathematics, 1993 -

Research Interests:

-
My primary research interest centers around laboratory testing in the pregnant patient including new ways to assess fetal lung maturity. Currently, there is no means by which to predict whether or not infants will be born with RDS. Other projects include collaborations with EUH faculty to assess hemostasis in the pregnant patient and risk of fetal demise.

- Clinical Chemistry
Investigation of potential markers for respiratory distress syndrome in neonates using proteomic techniques.

Clinical Focus:

I am the Director of the Core Laboratory at Emory Crawford Long Hospital and the Director of Point of Care Testing for Emory Healthcare.

Honors / Awards:

Hunter's Hope Postdoctoral Fellowship Award ($103,864)

, 1999 - 2001

Specialty Boards:

 ABCC American Board of Clinical Chemistry

Selected Publications:

Published and Accepted Research Articles -

Gronowski AM, Fantz CR, Parvin CA, Sokoll LJ, Wiley CL, Wener MH, Grenache DG. 2008. Use of Serum FSH to Identify Perimenopausal Women with Pituitary hCG. Clin Chem. 2008 Apr;54(4):652-6. Epub 2008 Feb 7.

Molinaro RJ, Szlam F, Levy JH, Fantz CR, Tanaka KA. 2008. Low Fibrinogen Levels with Clauss Method during Anticoagulation with Bivalriudin. Anesthesiology 109:1-1.

Snyder ML, Fantz CR. 2008. Cirrhosis originally diagnosed as nonalcoholic steatohepatitis. Clin Chem. 2008 Aug;54(8):1395-8.

Sheppard CA, Franks N, Nolte FS, Fantz CR. 2008. Improving Quality in an Emergency Department: A Laboratory Perspective. AJCP 130:573-577

Darshong Lin, Corinne R. Fantz, Beth Levy, Mohammed Rafi, Carole Volger, David Wanger, Mark S. Sands. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid -cell leukodystrophy more completely than AAV2. Molecular Therapy, 2005

Chelsea A. Sheppard, Robert C. Allen, Garth E. Austin, Andrew N. Young, Maria A. Ribeiro and Corinne R. Fantz (2005). Paraprotein Interference in Automated Chemistry Analyzers. Clin Chem 51: 1077-1078.

Young, P. P., Fantz, C. R., and Sands, M. S. (2004). VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency. Exp Neurol 188(1) 104-114.

Fantz, C. R., Powell, C., Karon, B., Dayal, M., Sadovsky, Y., Johari, V., Apple F., Gronowski, A. M. (2002). Assessing the Diagnostic Efficiency of TDx-FLM II to Predict RDS in the Newborn. Clin Chem 48(5):761-765.

Fantz, C., Shaw, D., Jennings, W., Forsthoefel, A., Kitchens, M., Phan, J., Minor, W., Lebioda, L., Berger, F., and Spencer, H. T. (2000). Drug-resistant Variants of Escherichia coli Thymidylate Synthase: Effects of Substitutions at Pro254. Mol. Pharm. 57: 359-366.

Fantz, C. R., Dagogo-Jack, S., Ladenson, J. H., Gronowski, A. M. (1999). Thyroid Function During Pregancy. Clin. Chem. 45 (12): 2250-2258.

Fantz, C. R., Shaw, D., Moore, J., and Spencer, H. T. (1998). Co-Expression of Dihydrofolate Reductase and Thymidylate Synthase Confers Resistance to Antifolates and Fluoropyrimidines. Biochem. Biophys. Res. Comm. 243: 6-12.

Book Chapters -

Sheppard, C.A. and Fantz, C.R. (2006) Bad to the bone, PTH: Low-turnover versus high-turnover osteodystrophy. In "Tietz's Applied Laboratory Medicine"

Fantz, C. R. and Gronowski, A.M. (2004). Thyroid Disease and Pregnancy: Assessment of the Mother. Chapter 8 In "Handbook of Clinical Laboratory Testing During Pregnancy." Humana Press, Totowa, NJ. 167-179.

Fantz, C. R. and Gronowski, A.M. (2002). Pregnancy and Hyperthyroidism. Chapter 16 In "Thyroid Eye Disease," Eds. Dutton, J.J. and Haik, B. G. Marcel Deckker, New York. 143-153.

Other Publications -

Molinaro RJ, Szlam F, Fantz CR, Tanaka KA. (2008) Low Fibrinogen Levels with Clauss Method during Anticoagulation with Bivalriudin. AACC, Washington DC

Sheppard C and Fantz CR (2007). Comparison of ACT methods from patients on Cardiopulmonary Bypass. AACC, Chicago, IL.

Schmotzer CL and Fantz CR (2007) Impact of Critical Value Cutoffs on Laboratory Operations ACLPS, SanDiego, CA.

Kossover C, Ritchie JC, Fantz CR (2006). The effect of hemolysis on PT and PTT. AACC, Chicago, IL

Sheppard C and Fantz CR (2006). The effect of providing a phlebotomist on ER sample turn around time. AACC, Chicago, IL.

Rugari, A., Gartzke, M. and Fantz, C.R. (2002). Establishing a prevalence for Krabbe Leukodystrophy. AACC: Newborn Screening Meeting. Lexington, KY.

Fantz, C. R. and Landt, M. (2002). The prevalence of borderline sweat-tests. AACC, Orlando, FL.

Fantz, C. R., Langford, K. E., Wilhite, T., Luchtman-Jones, L. (2002). In vitro stability of reticulocyte counts.

Fantz, C. R., D. A. Wenger, and M. S. Sands. (2001). Neonatal and In Utero Gene Transfer Utilizing Adeno-Associated Virus and Lentiviral Vectors for the Treatment of Krabbe's Disease. American Society of Gene Therapy. Seattle, WA.

Fantz, C. R., Powell, C., Karon, B., Parvin, C. A., Hankins, K., B., Dayal, M., Sadovsky, Y., Johari, V., Apple F., Gronowski, A. M. (2000). Assessing the Diagnostic Efficiency of TDx-FLM II to Predict RDS in the Newborn. AACC, San Francisco, CA.

Shaw, D., Jennings, W., Gambrell, E., Fantz, C. R., Spencer, H. T. (1998). American Society for Hematology.

Fantz, C. R.. and Spencer, H. T. (1997). Retroviral Gene Transfer of a Thymidylate Synthase-Dihydrofolate Resuctase Chimera Confers Fluropyrimidine and Antifolate Resistance. Biology and Marking Studies. American Society for Hematology.